|
MTX3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77772999999659E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02039999996906E-06 |
| Normal-vs-Stage2 |
6.382100E-02 |
| Normal-vs-Stage3 |
6.984200E-03 |
| Normal-vs-Stage4 |
7.493000E-01 |
| Stage1-vs-Stage2 |
6.318800E-01 |
| Stage1-vs-Stage3 |
7.096200E-01 |
| Stage1-vs-Stage4 |
5.593600E-01 |
| Stage2-vs-Stage3 |
5.825800E-01 |
| Stage2-vs-Stage4 |
6.862000E-01 |
| Stage3-vs-Stage4 |
5.060600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70729999999986E-05 |
| Normal-vs-AfricanAmerican |
2.442100E-03 |
| Normal-vs-Asian |
4.817000E-01 |
| Caucasian-vs-AfricanAmerican |
9.942400E-01 |
| Caucasian-vs-Asian |
7.754600E-01 |
| AfricanAmerican-vs-Asian |
7.888200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58920000004059E-06 |
| Normal-vs-Female |
3.481900E-02 |
| Male-vs-Female |
7.176500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.604000E-02 |
| Normal-vs-Extreme_Weight |
7.89929999966965E-07 |
| Normal-vs-Obese |
4.762500E-03 |
| Normal-vs-Extreme_Obese |
1.149650E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.544000E-01 |
| Normal_Weight-vs-Obese |
8.065400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.823800E-01 |
| Extreme_Weight-vs-Obese |
9.846200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.196600E-01 |
| Obese-vs-Extreme_Obese |
8.348400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.621400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.224260E-02 |
| Normal-vs-Age(61-80Yrs) |
2.51480000001969E-06 |
| Normal-vs-Age(81-100Yrs) |
4.45310000000143E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.820500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.413800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.744000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.933700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.546200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.257800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56048999999658E-05 |
| Normal-VS-Type2 PRCC |
1.821750E-03 |
| Normal-VS-KIRP CIMP |
3.92890000000534E-05 |
| Normal-VS-Unclassified PRCC |
1.583380E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.115400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.237590E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.798800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.017800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.312400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.423700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.95289999999271E-06 |
| Normal-vs-N1 |
4.568200E-01 |
| Normal-vs-N2 |
1.489850E-02 |
| N0-vs-N1 |
2.104800E-01 |
| N0-vs-N2 |
9.451800E-01 |
| N1-vs-N2 |
5.710800E-01 |
|
|
